pd168393 has been researched along with camptothecin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Amico, M; Lodola, A; Marchetti, C; Milelli, A; Minarini, A; Mor, M; Nicolini, B; Pruccoli, L; Simoni, E; Tarozzi, A; Ticchi, N; Tumiatti, V | 1 |
1 other study(ies) available for pd168393 and camptothecin
| Article | Year |
|---|---|
Combined inhibition of the EGFR/AKT pathways by a novel conjugate of quinazoline with isothiocyanate.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Humans; Isothiocyanates; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; Sulfoxides | 2016 |